RESEARCH PAPER
Genital warts and condom use in HIV-positive patients referred to
High-Risk Behaviors Consultation Center in Shiraz, Iran, between 2018 and 2019
1
Maternal-Fetal Medicine Research Center, Department of Midwifery, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran
2
Community-Based Psychiatric Care Research Center, Department of Midwifery, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran
Submission date: 2021-10-08
Final revision date: 2021-12-21
Acceptance date: 2021-12-25
Publication date: 2022-04-04
HIV & AIDS Review 2022;21(2):169-174
KEYWORDS
TOPICS
ABSTRACT
Introduction:
People with untreated human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) are more prone to present active human papillomavirus (HPV) infections, and may experience worse symptoms of HPV, such as cervical and penile warts. Therefore, HPV prevention is especially important in HIV-positive individuals. This study aimed to investigate the frequency of genital warts and condom use in sexually active individuals with HIV/AIDS treated in the Behavioral Counseling Center of Shiraz.
Material and methods:
224 HIV-positive subjects (112 males and 112 females) were included in this cross-sectional study, selected from database of the Behavioral Counseling Center of Shiraz, with simple random sampling. Data were collected using demographic questionnaires, interviews, and medical records.
Results:
Genital warts were reported only in 13.4% of women and 17.0% of men, and the percentage of condom use among women and men was 65.2% and 74.1%, respectively. Moreover, 68.8% of men and 87.5% of women presented first stage of HIV infection.
Conclusions:
According to the results, condoms were the most commonly used form of contraception in women and men with HIV/AIDS, and genital warts were reported only in 13.4% of women and 17% of men, few of whom did not use any contraception. Due to high percentage of genital warts among participants, there is a need to encourage these patients to use condoms due their protective effects and reduction of cervical and penile lesions.
People with untreated human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) are more prone to present active human papillomavirus (HPV) infections, and may experience worse symptoms of HPV, such as cervical and penile warts. Therefore, HPV prevention is especially important in HIV-positive individuals. This study aimed to investigate the frequency of genital warts and condom use in sexually active individuals with HIV/AIDS treated in the Behavioral Counseling Center of Shiraz.
Material and methods:
224 HIV-positive subjects (112 males and 112 females) were included in this cross-sectional study, selected from database of the Behavioral Counseling Center of Shiraz, with simple random sampling. Data were collected using demographic questionnaires, interviews, and medical records.
Results:
Genital warts were reported only in 13.4% of women and 17.0% of men, and the percentage of condom use among women and men was 65.2% and 74.1%, respectively. Moreover, 68.8% of men and 87.5% of women presented first stage of HIV infection.
Conclusions:
According to the results, condoms were the most commonly used form of contraception in women and men with HIV/AIDS, and genital warts were reported only in 13.4% of women and 17% of men, few of whom did not use any contraception. Due to high percentage of genital warts among participants, there is a need to encourage these patients to use condoms due their protective effects and reduction of cervical and penile lesions.
REFERENCES (28)
1.
Chikandiwa A, Kelly H, Sawadogo B, et al. Prevalence, incidence and correlates of low risk HPV infection and anogenital warts in a cohort of women living with HIV in Burkina Faso and South Africa. PLoS One 2018; 13: e0196018.
2.
Adenis A, Dufit V, Douine M, et al. High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study. Epidemiol Infect 2017; 145: 1276-1284.
3.
Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG. Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing. Viruses 2018; 10: 729.
4.
Aleksioska-Papestiev I, Chibisheva V, Micevska M, Dimitrov G. Prevalence of specific types of human papiloma virus in cervical intraepithelial lesions and cervical cancer in Macedonian women. Med Arch 2018; 72: 26-30.
5.
Clifford GM, Tully S, Franceschi S. Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer. Clin Infect Dis 2017; 64: 1228-1235.
6.
Khodabandehloo P, Vadiea S, Malekafzali Ardakani B. The sociological explanation of the genital wart outbreak; case study of patients treated in Bouali and Javaheri Hospitals in Tehran. Medical Science Journal of Islamic Azad Univesity-Tehran Medical Branch 2018; 28: 245-251.
7.
Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol 2017; 40: 80-85.
8.
Abel S, Najioullah F, Voluménie JL, et al. High prevalence of human papillomavirus infection in HIV-infected women living in French Antilles and French Guiana. PLoS One 2019; 14: e0221334. doi: 10.1371/journal.pone.0221334.
9.
Mirzazadeh A, Shokoohi M, Khajehkazemi R, et al. HIV and sexually transmitted infections among female sex workers in Iran: findings from the 2010 and 2015 national surveillance surveys. AIDS Conference; 2016.
10.
Gautam A, Chakravarty J, Singh VK, et al. Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India. BMC Infect Dis 2018; 18: 692.
11.
Nelson LE, Tharao W, Husbands W, et al. The epidemiology of HIV and other sexually transmitted infections in African, Caribbean and Black men in Toronto, Canada. BMC Infect Dis 2019; 19: 294.
12.
Long JE, Waruguru G, Yuhas K, et al. Prevalence and predictors of unmet contraceptive need in HIV-positive female sex workers in Mombasa, Kenya. PLoS One 2019; 14: e0218291.
13.
Rwamugira J, Maree JE, Mafutha N. The knowledge of South African men relating to cervical cancer and cervical cancer screening. J Cancer Educ 2019; 34: 130-136.
14.
Nasirian M, Kianersi S, Hoseini SG, et al. Prevalence of sexually transmitted infections and their risk factors among female sex workers in Isfahan, Iran: a cross-sectional study. J Int Assoc Provid AIDS Care 2017; 16: 608-614.
15.
Ghazizadeh S, Lessan-Pezeshki M, Nahayati MA. Human papilloma virus infection in female kidney transplant recipients. Saudi J Kidney Dis Transpl 2011; 22: 433-436.
16.
Deese J, Pradhan S, Goetz H, Morrison C. Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives. Open Access J Contracept 2018; 9: 91-112.
17.
Corrêa CM, Teixeira NCP, de Araújo ACL, et al. Prevalence and multiplicity of HPV in HIV women in Minas Gerais, Brazil. Rev Assoc Med Bras (1992) 2011; 57: 425-430.
18.
Tran LT, Tran LT, Bui TC, et al. Risk factors for high-risk and multi-type Human Papillomavirus infections among women in Ho Chi Minh City, Vietnam: a cross-sectional study. BMC Womens Health 2015; 15: 16.
19.
Yu Q, Liu Q, Gao Y, et al. Human papillomavirus type 18/16 infection and prevalence among middle-aged and older Chinese rural women: a cross-sectional survey in Wufeng, Hubei Province. Women Health 2019; 59: 1105-1117.
20.
Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 2010; 10: 862-874.
21.
Shew ML, Ermel AC, Tong Y, Tu W, Qadadri B, Brown DR. Episodic detection of human papillomavirus within a longitudinal cohort of young women. J Med Virol 2015; 87: 2122-2129.
22.
Kumar N, Sarinoglu C. 044 Epidemiology of HPV risk factors and birth control methods between HPV positive and HPV negative women in rural Arkansas. J Sex Med 2019; 16: S20.
23.
Pierce Campbell CM, Lin HY, Fulp W, et al. Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study. J Infect Dis 2013; 208: 373-384.
24.
Badial RM, Dias MC, Stuqui B, et al. Detection and genotyping of human papillomavirus (HPV) in HIV-infected women and its relationship with HPV/HIV co-infection. Medicine 2018; 97: e9545.
25.
De Camargo CC, Tasca KI, Mendes MB, Miot HA, de Souza Ldo R. Prevalence of anogenital warts in men with HIV/AIDS and associated factors. Open AIDS J 2014; 8: 25-30.
26.
Human papillomavirus (HPV) in patients with HIV. Availbale at: https://www.hivguidelines.org/....
27.
Guo F, Hirth JM, Berenson AB. Human papillomavirus vaccination and pap smear uptake among young women in the United States: role of provider and patient. J Womens Health (Larchmt) 2017; 26: 1114-1122.
28.
Anderson A, Taylor Z, Georges R, et al. Primary care physicians’ role in parental decision to vaccinate with HPV vaccine: learnings from a South Texas Hispanic patient population. J Immigr Minor Health 2018; 20: 1236-1242.
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
